Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors.

We describe a rapid and simple insulin RIA in which proinsulin and conversion intermediates do not interfere. Three monoclonal antibodies (S1, S2, and S53) were selected for their specificity (directed, respectively, against the B10 region, the junction between A chain and C-peptide, and the junction between B chain and C-peptide), their affinity constant (approximately 10(10) L/mol), and their interactive properties in mixture. S2 and S53 were able to bind simultaneously to the same proinsulin molecule, whereas neither could bind simultaneously with S1. Preincubation of serum samples with an excess of S2 resulted in capture of proinsulin and conversion intermediates modified at the junction between B chain and C-peptide into immune complexes that no longer reacted with S1. Similarly, preincubation with S53 prevented proinsulin and conversion intermediates modified at the junction between A chain and C-peptide from reacting with S1. Preincubation with an excess of both S2 and S53 left insulin as the sole reactant with S1. Thus, separation of insulin precursors from insulin by mutually exclusive antibodies is feasible, and on the basis of this new principle, a highly specific RIA for insulin was designed. The detection limit was 11 pmol/L, and the inter- and intraassay coefficients of variation were 11% and 5%, respectively. The potential of the assay for use in clinical studies was verified by application to serum samples from control subjects and patients with diabetes or insulinoma.

[1]  P. Halban,et al.  Slow cleavage at the proinsulin B-chain/connecting peptide junction associated with low levels of endoprotease PC1/3 in transformed beta cells. , 1993, The Journal of biological chemistry.

[2]  P. Halban,et al.  Kinetics of Proinsulin Conversion in Human Islets , 1993, Diabetes.

[3]  M. Røder,et al.  Enzyme immunoassay for intact human insulin in serum or plasma. , 1993, Clinical chemistry.

[4]  W. Sheu,et al.  Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. , 1993, The Journal of clinical endocrinology and metabolism.

[5]  S. Shoelson,et al.  Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing. , 1992, The Journal of biological chemistry.

[6]  A. Montag,et al.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Crowther,et al.  Sensitive Amplified Immunoenzymometric Assays (IEMA) for Human Insulin and Intact Proinsulin , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[8]  D. Accili,et al.  Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction. , 1990, The Journal of clinical endocrinology and metabolism.

[9]  D. Owens,et al.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. , 1989, The Biochemical journal.

[10]  D. Owens,et al.  INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[11]  M. Nattrass,et al.  Insulin and Proinsulin Concentrations in Patients with Insulinoma before and after Surgical Treatment , 1988 .

[12]  H. Davidson,et al.  Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic β cell via two distinct site-specific endopeptidases , 1988, Nature.

[13]  H. Davidson,et al.  The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. , 1987, The Biochemical journal.

[14]  K. Kangawa,et al.  High plasma concentrations of human atrial natriuretic polypeptide in aged men. , 1987, The Journal of clinical endocrinology and metabolism.

[15]  K. Polonsky,et al.  Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. , 1986, Metabolism: clinical and experimental.

[16]  K. Rother,et al.  Insulin and Anti-Insulin Antibody Interaction: Evidence for the Formation of 7 S and 10 S Structures , 1985, Diabetes.

[17]  K. Docherty,et al.  Carboxypeptidase activity in the insulin secretory granule , 1983, FEBS letters.

[18]  L. Orci,et al.  Functional and Morphologic Characterization of Human Insulinomas , 1983, Diabetes.

[19]  A. Rubenstein,et al.  Circulating proinsulin in patients with maturity onset diabetes. , 1977, The American journal of medicine.

[20]  K. Gabbay,et al.  Familial hyperproinsulinemia. An autosomal dominant defect. , 1976, The New England journal of medicine.

[21]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[22]  D. Steiner,et al.  Proteolytic processing in the biosynthesis of insulin and other proteins. , 1974, Federation proceedings.

[23]  B. Brodal.  The influence of haemolysis on the radioimmunoassay of insulin. , 1971, Scandinavian journal of clinical and laboratory investigation.

[24]  L. Stimmler.  Immunoassay of insulin with insulin antibody precipitate. , 1963, Lancet.

[25]  S. Berson,et al.  Assay of Plasma Insulin in Human Subjects by Immunological Methods , 1959, Nature.

[26]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .